Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2015

Oct 19, 2015

5262_dirs_2015-10-19_2583791b-649a-4d02-9dea-b1babf283d53.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7116C

GlaxoSmithKline PLC

19 October 2015

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons

In accordance with DTR 3.1.4R(1)(a) and (c) I give details of changes in the interests of the following Directors and Persons Discharging Managerial Responsibilities ('PDMR') who acquired Ordinary Shares ('Shares') in GlaxoSmithKline plc ('GSK') at a price of 1294.81 pence per Share, following the re-investment of the dividend paid to shareholders on 1 October 2015.

Director/PDMR Shares
Sir Andrew Witty 29.783
Mr R G Connor 247.313
Mr S Dingemans 975.733
Mr S A Hussain 2,232.502
Mr D S Redfern 846.893
Dr M M Slaoui 171.202
Ms C Thomas 1,039.600
Mr P C Thomson 355.850
Dr P J T Vallance 1,260.356
Ms E Walmsley 977.510
Connected Person Shares
Mrs K Thomson (Connected Person to Mr P C Thomson) 114.588

GSK was informed of these allocations on 16 October 2015.

V A Whyte

Company Secretary

19 October 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSXKLFFEBFXFBX